Helsingborg, Sweden

Birgitta Termander


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Birgitta Termander: Innovator in Hematology

Introduction

Birgitta Termander is a notable inventor based in Helsingborg, Sweden. She has made significant contributions to the field of hematology, particularly through her innovative research and patenting activities. Her work focuses on improving treatments for patients undergoing bone marrow transplantation and related therapies.

Latest Patents

Birgitta Termander holds a patent for the use of Linomide, specifically N-phenyl-N-methyl-1,2-dihydro-4-hydroxy-1-methyl-2-oxo-quinoline-3-carboxamide. This invention is aimed at increasing hemopoietic cell precursors in humans subjected to bone marrow transplantation, cytostatic treatments, irradiations, or combinations thereof. This patent represents a significant advancement in therapeutic options for patients facing serious medical challenges.

Career Highlights

Throughout her career, Termander has been associated with Pharmacia AB, where she has contributed to various research initiatives. Her dedication to advancing medical science has positioned her as a key figure in her field. With a focus on innovative solutions, she continues to impact the lives of many patients through her work.

Collaborations

Birgitta has collaborated with esteemed colleagues, including Bo Nilsson and Terje Kalland. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in hematology.

Conclusion

Birgitta Termander's contributions to the field of hematology through her patent and collaborative efforts highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments, benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…